Development of a Core Outcome Set for the Benefits and Adverse Events of Acute Heart Failure in Clinical Trials of Traditional Chinese Medicine and Western Medicine: A Study Protocol

Frontiers in Medicine

article

Ruijin Qiu¹  Hongcai Shang¹  Songjie Han¹  Xuxu Wei¹  Changming Zhong¹  Min Li²  Jiayuan Hu¹  Pengqian Wang¹  Chen Zhao⁴  Jing Chen⁵ 

[1] Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Beijing University of Chinese Medicine Affiliated Dongzhimen Hospital;Beijing University of Chinese Medicine Third Affiliated Hospital;Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences;Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences;Baokang Affiliated Hospital of Tianjin University of Traditional Chinese Medicine

关键词: acute heart failure;    core outcome set;    integrative medicine;    methodology;    safety and efficacy;    study protocol;   

DOI  :  10.3389/fmed.2021.677068

学科分类：社会科学、人文和艺术（综合）

来源: Frontiers

【 摘 要 】

Aims: To identify a minimum set of efficacy and adverse events for patients with acute heart failure (AHF) among different stakeholders in clinical trials of traditional Chinese medicine and Western medicine. Methods and Analysis: First, we will develop a preliminary long list of outcomes that includes efficacy and adverse events/reactions via three steps: (i) systematic reviews of efficacy and safety outcomes for clinical trials of AHF; (ii) drugs included in the National Medical Insurance Catalog, the National Essential Medicines Catalog, and the WHO Essential Medicines List will be collected and safety outcomes extracted from the package inserts; and (iii) patients' or caregivers' semi-structured interviews will be carried out to add new viewpoints to the list. Second, after merging outcomes and grouping them under different outcome domains, questionnaires for health professionals and patients will be separately developed. Further, two rounds of Delphi survey for health professionals and a survey for patients and the public will be carried out. Third, different stakeholders will discuss and determine the final core outcome set (COS) for AHF in a consensus meeting. Ethics and Dissemination: The entire project has been approved by the Ethics Committee of the main institution. After the final COS is developed, it will be published and discussed widely in conferences. Clinical Trial Registration: This study is registered with the Core Outcome Measures in Effectiveness Trials database as study 1566 (available at: https://www.cometinitiative.org/Studies/Details/1566 ).

【 授权许可】

CC BY